Compare AVAH & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVAH | BHVN |
|---|---|---|
| Founded | 1984 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 2021 | 2022 |
| Metric | AVAH | BHVN |
|---|---|---|
| Price | $7.30 | $10.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 14 |
| Target Price | $10.56 | ★ $27.69 |
| AVG Volume (30 Days) | 1.0M | ★ 1.9M |
| Earning Date | 04-22-2026 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.55 | 26.08 |
| EPS | ★ 0.22 | N/A |
| Revenue | ★ $2,024,506,000.00 | N/A |
| Revenue This Year | $21.81 | N/A |
| Revenue Next Year | $5.96 | N/A |
| P/E Ratio | $33.70 | ★ N/A |
| Revenue Growth | ★ 6.82 | N/A |
| 52 Week Low | $3.67 | $7.48 |
| 52 Week High | $10.32 | $31.87 |
| Indicator | AVAH | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 38.16 | 42.16 |
| Support Level | $3.81 | $10.75 |
| Resistance Level | $8.54 | $15.66 |
| Average True Range (ATR) | 0.30 | 0.65 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 26.64 | 12.74 |
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.